Strengthens Portfolio in Pod Shatter Reduction, Herbicide Tolerances, High Fiber Wheat, and Improved Quality Alfalfa; Covers Europe, Asia, Latin America, Canada, and the U.S.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/29/2024 | $25.00 | Buy | Alliance Global Partners |
| 7/19/2024 | $22.00 | Buy | Canaccord Genuity |
| 10/9/2023 | $25.00 | Buy | H.C. Wainwright |
| 7/19/2023 | $30.00 | Buy | Canaccord Genuity |
Alliance Global Partners initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00
Canaccord Genuity resumed coverage of Cibus Global with a rating of Buy and set a new price target of $22.00
H.C. Wainwright initiated coverage of Cibus Global with a rating of Buy and set a new price target of $25.00
Canaccord Genuity analyst Austin Moeller assumes Cibus (NASDAQ:CBUS) with a Buy rating and announces Price Target of $22.
Strengthens Portfolio in Pod Shatter Reduction, Herbicide Tolerances, High Fiber Wheat, and Improved Quality Alfalfa; Covers Europe, Asia, Latin America, Canada, and the U.S.
On Wednesday, Cibus Inc (NASDAQ:CBUS) announced that it has expanded its intellectual property coverage for ten gene editing and trait families. Over the last six months, intellectual property expansion has covered several areas, including gene editing, productivity traits, and quality traits, like high-fiber wheat. This strengthens the company’s patent coverage in geographies including, but not limited to, Europe, Asia, Latin America, Canada, and the U.S. Cibus is focused on developing complex gene-edited traits in plants, such as Pod Shatter Reduction in Canola and Herbicide Tolerance in Rice. The company’s plant trait intellectual property is developed using its Rapid Trait De
Announced a strategic realignment to advance commercial opportunities, focusing resources on advancement of weed management platform (HT1 and HT3) for Rice, Pod Shatter Reduction in Canola, Sclerotinia resistance for Canola and Soybean, and on Soybean platform development Great progress in Rice as we execute on our agreements with four major seed company customers in the United States and Latin America, with germplasm received from all customers; completed successful field trials with HT3 in customer germplasm, as well as completed what the Company believes to be the first field trials for stacked gene-edited herbicide tolerance traits Also in Rice, signed an Agreement with RTDC Corporatio
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report third quarter 2024 financial results on Thursday, November 7, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2024 Results Conference Call Event Date: Thursday, November 7, 2024 Time: 4:30 p.m. ET Participant Numbers: +1-877-300-8521 (U.S.), +1-412-317-6026 (International) Event Link: https:/
Demonstrated continued momentum securing an agreement for its Herbicide Tolerance (HT) traits in Rice with a fourth customer in the second quarter with signing of agreement with Federacion Nacional de Arroceros ("FEDEARROZ"); builds on prior agreements with Loveland Products, Inc., a subsidiary of Nutrien, Ltd., in the United States and with Interoc S.A. in Latin America Rice platform is the Company's first entry into the major global grain crops with significant potential commercial opportunities Wheat platform operational, enables Cibus access into the largest global grain crop in planted acres Continued achievement of milestones in the development of its Advanced Trai
Announced a strategic realignment to advance commercial opportunities, focusing resources on advancement of weed management platform (HT1 and HT3) for Rice, Pod Shatter Reduction in Canola, Sclerotinia resistance for Canola and Soybean, and on Soybean platform development Great progress in Rice as we execute on our agreements with four major seed company customers in the United States and Latin America, with germplasm received from all customers; completed successful field trials with HT3 in customer germplasm, as well as completed what the Company believes to be the first field trials for stacked gene-edited herbicide tolerance traits Also in Rice, signed an Agreement with RTDC Corporatio
The greenhouse results represent an important success milestone in the development of its second-generation of HT2 edited Canola Cibus expects to initiate seed bulk up for testing in fields in 2025 SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that its next generation edits for herbicide tolerance (HT2) in Canola have shown increased tolerance to the herbicide in greenhouse testing. With the achievement of this milestone, seed from these edited plants will be utilized to initiate larger scale field testing in the 2025 season. Reachi
SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that the company will report third quarter 2024 financial results on Thursday, November 7, 2024. Cibus' management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2024 Results Conference Call Event Date: Thursday, November 7, 2024 Time: 4:30 p.m. ET Participant Numbers: +1-877-300-8521 (U.S.), +1-412-317-6026 (International) Event Link: https:/
10-Q - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
8-K - Cibus, Inc. (0001705843) (Filer)
3 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
4 - Cibus, Inc. (0001705843) (Issuer)
Cibus Announces Election of New Board Member, Deepening Strategic Leadership and Experience SAN DIEGO, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a global leader in Gene Editing in agriculture and the development of Productivity Traits in plants that directly impact farming productivity and profitability announced that its Board of Directors has elected Jim Collins, former CEO of Corteva, to the Board. "Jim brings to Cibus immense knowledge and strategic vision on the direction of the future role and use of Gene Editing in agriculture," said Mark Finn, Chair of the Audit Committee. "Jim's experience leading one of the largest agricultural and seed companies will gi
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, announced today the appointment of Steve Berreth as General Counsel and Corporate Secretary for the corporation. Mr. Berreth was previously Vice President, General Counsel and Secretary for Syngenta Crop Protection LLC, the North American Subsidiary of Syngenta AG, one of the world's largest biotechnology agribusinesses and one of the largest crop protection chemical and seed businesses in the world. He was a member of the Syngenta global legal and compliance leadership teams and led the North American le